OPINION | South India’s Tier-2 cities are quietly redefining healthcare

For years, India’s healthcare conversation has been dominated by a familiar cast of metros: Chennai, Bengaluru, and Hyderabad. Yet the most interesting part of the story is now unfolding a tier below, in cities like Coimbatore, Madurai, Tiruchirappalli, Mangaluru, and Hubballi–Dharwad. These are dense, fast-growing service economies with rising non-communicable disease burdens, robust private sectors, and increasingly assertive patients.

South India starts from a structurally different base. Kerala, Tamil Nadu, and Telangana consistently rank near the top of successive NITI Aayog health-index rankings, with Karnataka not far behind. These outcomes reflect decades of investment in education, primary care, and institutional delivery, layered over relatively effective state machinery and strong private participation. The result is a long-running virtuous cycle: educated population, early public-health gains, dense medical-education capacity, and a large private footprint reinforcing one another.

In that context, South India’s Tier-2 cities are beginning to function as regional health systems in their own right, rather than merely feeders to the metros.

A Southern Advantage Built Over Decades

Southern states host a disproportionately large share of India’s medical colleges, particularly in the private sector. That matters less as a bragging right than as a practical source of human capital: more doctors, specialists, and nurses per capita, and a deeper bench willing to live and work in smaller cities. This training ecosystem anchors tertiary centers and makes it structurally easier to sustain higher-end services in Tier-2 locations.

At the same time, early investments in maternal and child health, immunisation, and family planning produced better outcomes and higher life expectancy than national averages. Higher literacy and health awareness translate into earlier care-seeking, greater acceptance of institutional care, and more informed demand for quality.

South India looks less like a patchwork of isolated facilities and more like a set of hybrid ecosystems. Public and private sectors coexist; competition, referral linkages, and patient expectations have collectively raised the baseline standard of care.

Prototype Hubs in Some Cities

Within this landscape, a handful of Tier-2 cities have emerged as “prototype hubs.”

Coimbatore is one of the clearest examples: an industrial and educational city with an international airport, Gulf connectivity, and a catchment spanning western Tamil Nadu and parts of Kerala. It already hosts multiple tertiary hospitals and diagnostic chains, yet its mid-market remains fragmented. There is ample room for 100–200-bed hospitals that bring Tier-1-style governance and protocols to middle-income neighborhoods and peripheral suburbs.

Madurai and Tiruchirappalli play similar roles in southern and central Tamil Nadu. Both have functioning airports, large migrant and diaspora links, and broad catchments reaching into multiple districts. They host mission, trust, and corporate hospitals, yet patients still travel to Chennai or Coimbatore for certain specialties and higher-acuity services. This pattern of partial self-sufficiency with visible leakage suggests strong potential for focused, protocol-driven mid-sized hospitals in rapidly urbanising corridors around the core cities.

On the western coast, Mangaluru leverages an international airport, Konkan road and rail links, and a dense cluster of medical and nursing colleges. It attracts patients from coastal Karnataka, northern Kerala, and interior coffee country for complex surgery, cardiac care, and oncology. Yet services remain concentrated in a few large campuses, leaving white space for mid-sized multi-specialty hospitals in peripheral taluks and satellite facilities tied more tightly into primary and secondary care.

Hubballi–Dharwad represents a different kind of prototype: an emerging commercial and educational hub for North Karnataka, with growing air connectivity and a catchment extending into southern Maharashtra and parts of Goa for certain services. Historically, complex cardiac and oncology cases moved almost automatically to Bengaluru or Pune. Recent investments have begun to reverse some of this outflow, but general multi-specialty capacity beyond a handful of institutions remains uneven. That makes 100–150-bed high-acuity hospitals particularly viable.

Across these cities, the pattern is consistent: sufficient air connectivity to move specialists and patients, sizeable multi-district catchments with rising non-communicable disease burdens and paying power, partially developed but not saturated tertiary ecosystems, and ongoing out-migration of complex cases. These conditions are precisely where the next wave of well-run Tier-2 hospitals can be both impactful and profitable.

Ecosystems, Not Stand-Alone Hospitals

In these hubs, the symbiotic relationship between private hospitals and the surrounding ecosystem—medical colleges, nursing schools, and local MedTech manufacturers and distributors—is not a luxury; it is structurally critical.

Medical and nursing colleges provide the talent pipeline needed to run 24/7 emergency, ICU, and operative services without relying entirely on specialists imported from metros. Teaching hospitals and established centers raise the bar on case complexity, making it easier for mid-sized hospitals to plug into referral networks, share visiting consultants, run joint clinics, and host DNB programs.

In cities like Coimbatore and Mangaluru, dense clusters of colleges and emerging MedTech activity create quasi-clusters where hospitals can access trained staff, research collaborators, and early access to devices and diagnostics tailored to Tier-2 price points. In Hubballi–Dharwad, partnerships for training and continuing education are often the only way to lock in a sustainable workforce and justify adding beds.

From Distressed City Hospital to Regional Anchor

A distressed 250-bed doctor-promoted hospital in a prominent North Karnataka hub illustrates how capital and governance can unlock regional healthcare value. A decade ago, the asset was in crisis. Burdened by ₹120 crore in debt, it struggled with stagnant 30% occupancy and negative EBITDA on revenues of roughly ₹30 crore.

The turnaround—led through a control-oriented buyout—involved a comprehensive reset:

Capital and structure: New equity was injected at a discount, debt was restructured, and promoter doctors were realigned around departmental ownership.

Operational rigor: Governance, cost discipline, and clinical throughput were institutionalized through a focused operating program.

Performance swing: Within five years, revenues climbed to about ₹80 crore, EBITDA turned strongly positive, and occupancy surged past 70%.

By stabilising the balance sheet and professionalising management, the facility evolved from a struggling city hospital into a default tertiary anchor for the surrounding region, capturing complex cases that previously migrated to metros such as Bengaluru or Pune. Variations of this story are now possible across multiple Tier-2 hubs that share similar catchments, balance-sheet stress, and ecosystem advantages.

Patients as Pragmatic Adopters

Patient behaviour in these cities is also changing in ways that favour credible local platforms.

Smartphone and data penetration are high, but Tier-2 patients are not chasing every new health app. They prefer hospital-anchored, vernacular, low-friction digital journeys that clearly save time and money. In one Tier-2 hub within our ecosystem, more than 50% of follow-up consultations for stable chronic patients have shifted to hospital-anchored teleconsultations or structured WhatsApp-style OPDs. This shift has reduced no-show rates and travel burdens without eroding clinical trust, because patients know the digital interface is backed by a physical hospital they can visit when necessary.

Prevention follows a similarly pragmatic pattern. Post-COVID, families are more willing to pay for periodic health checks or targeted screening for diabetes, hypertension, and cancer risk—but only when pricing is transparent and the link to avoided risk is explicit. “Defensive prevention,” spending modestly now to avoid catastrophic hospitalisation later, tends to outweigh lifestyle-oriented wellness programs.

This combination makes South India’s Tier-2 cities ideal test beds for “India-fit” hardware–software combinations. Hospitals and diagnostic chains pilot mid-tier imaging, point-of-care diagnostics, and ICU technologies that must prove themselves on clinical performance, durability, and affordability simultaneously.

The Investment Lens

From a fund manager’s perspective, the most compelling opportunities in this geography are 75–250-bed regional anchors and specialised ambulatory networks linked to these hubs.

The entry logic typically focuses on identifying underperforming but strategically located Tier-2 assets where a proven operating playbook can unlock value. EBITDA expansion usually comes through occupancy improvement, case-mix optimisation, governance upgrades, and disciplined cost management.

By professionalising standalone facilities into cohesive regional platforms, investors create a clear pathway for exit—either through strategic roll-ups by national chains or through public listings that tap the premium multiples commanded by scaled healthcare assets.

A Ten-Year View

Look ahead a decade, and a self-sustaining Tier-2 healthcare ecosystem in South India is easy to imagine.

Each hub city could host two or three NABH-grade multi-specialty hospitals with strong emergency care, ICUs, obstetrics, pediatrics, orthopedic trauma, general surgery, and internal medicine. Diagnostics, devices, and digital infrastructure would be fully embedded: advanced imaging, cath labs where justified, regional lab hubs with satellite collection networks, and interoperable hospital systems linked to personal health records.

Public schemes such as Ayushman Bharat PM-JAY—offering ₹5 lakh of coverage per eligible household for secondary and tertiary care—along with private insurers and employers, would increasingly contract on value, steering patients to these Tier-2 networks for all but the most complex cases.

In such a system, South Indian Tier-2 ecosystems could manage 70–80 percent of cases that today still travel to metros, sending only the most complex 20–30 percent to cities like Chennai, Bengaluru, or Hyderabad.

The real question is whether operators, investors, and policymakers are ready to treat these cities not as peripheral markets, but as the places where India’s next decade of healthcare innovation will actually be built and tested.

(Rakshith Rangarajan is Equity Fund Manager at Inviga Investment Advisors Private Limited.)

Views are personal, and do not represent the stand of this publication.